Glucagon-like peptide-1 infusion must be maintained for 24 h/day to obtain acceptable glycemia in type 2 diabetic patients who are poorly controlled on sulphonylurea treatment
(Q43687918)
scientific article published in August 2001
scientific article published in August 2001
Language:
| (P31) |
(Q13442814)
|
||||||||||||||||||||||||||||||||
| (P304) |
1416-1421
|
||||||||||||||||||||||||||||||||
| (P407) |
(Q1860)
|
||||||||||||||||||||||||||||||||
| (P433) |
8
|
||||||||||||||||||||||||||||||||
| (P478) |
24
|
||||||||||||||||||||||||||||||||
| (P577) |
Wednesday, August 1, 2001
|
||||||||||||||||||||||||||||||||
| (P1433) |
(Q5270111)
|
||||||||||||||||||||||||||||||||
| (P1476) |
"Glucagon-like peptide-1 infusion must be maintained for 24 h/day to obtain acceptable glycemia in type 2 diabetic patients who are poorly controlled on sulphonylurea treatment" (language: en)
|
||||||||||||||||||||||||||||||||
| (P2093) |
Larsen J
Hylleberg B
Ng K
Damsbo P
|